Abstract
Purpose
Bariatric surgery is the most effective treatment of morbid obesity. Bariatric procedures employ different mechanisms of action to induce weight loss. The present study aimed to compare single-anastomosis sleeve ileal (SASI) bypass and roux-en-Y gastric bypass RYGB with long biliopancreatic limb (BPL) in terms of weight loss, remission of comorbidities, complications, and nutritional status.
Methods
This was a single-center cohort study on patients with morbid obesity who underwent RYGB with long BPL of 150 cm or SASI bypass. The main outcome measures were weight loss and improvement in comorbidities at 12 months, nutritional status, and complications.
Results
The present study included 92 patients (59.8% females) of a mean age of 38.4 years and mean BMI of 42 kg/m2. RYGB and SASI bypass were followed by a significant decrease in body mass index at 12 months and were comparable in terms of excess and total weight loss. Improvement in comorbidities after the two procedures was similar. The serum albumin levels showed a significant decline after RYGB, but not after SASI bypass. The postoperative serum iron levels were higher after SASI bypass than after RYGB. There was no significant difference in regard to complication rates (13% vs 4.3%, p = 0.27).
Conclusions
RYGB with long BPL and SASI bypass achieved satisfactory weight loss and improvement in comorbidities that were comparable among the two groups. Long BPL RYGB was followed by a significant decrease in serum albumin and iron levels at one year, which was not observed after SASI bypass.
Similar content being viewed by others
References
Higa K, Ho T, Tercero F, et al. Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up. Surg Obes Relat Dis. 2011;7:516–25.
Wittgrove AC, Clark W. Laparoscopic gastric bypass, Roux-en-Y – 500 patients: tech nique and results, with 3-60 months follow-up. Obes Surg 2000; 10: 233- 9. Drazen, S.C. Woods, Peripheral signals in the control of satiety and hun- ger, Curr. Opin. Clin. Nutr. Metabol. Care 6 (2003) 621e629.Stefanidis D, Kuwada TS, Gersin KS. The importance of the length of the limbs for gastric bypass patients–an evidence-based review. Obes Surg. 2011;21:119–24.
Tacchino RM. Bowel length: measurement, predictors and impact on bariatric and metabolic surgery. Surg Obes Relat Dis. 2015;11:328–34.
Santoro MCP, Velhote CE, Malzoni, et al. Digestive adaptation: a new surgical proposal to treat obesity based in physiology and evolution. Einstein. 2003;1(2):99e104.
Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256(1):104–10. https://doi.org/10.1097/SLA.0b013e31825370c0.
Mahdy T, Emile SH, Madyan A, et al. Evaluation of the efficacy of single anastomosis sleeve ileal (SASI) bypass for patients with morbid Obesity: a multicenter study. Obes Surg. 2020 Mar;30(3):837–45. https://doi.org/10.1007/s11695-019-04296-3.
Emile SH, Madyan A, Mahdy T, et al. Single anastomosis sleeve ileal (SASI) bypass versus sleeve gastrectomy: a case-matched multicenter study. Surg Endosc. 2021 Feb;35(2):652–60. https://doi.org/10.1007/s00464-020-07430-w.
Mahdy T, Gado W, Alwahidi A, et al. Sleeve gastrectomy, one-anastomosis gastric bypass (OAGB), and single anastomosis sleeve ileal (sasi) bypass in treatment of morbid obesity: a retrospective cohort study. Obes Surg. 2021;31:1579–89. https://doi.org/10.1007/s11695-020-05159-y.
Brethauer SA, Kim J. E Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Obes Surg. 2015;25(4):587–606. https://doi.org/10.1007/s11695-015-1645-3.
Homan J, Boerboom A, Aarts E, et al. A longer biliopancreatic limb in Roux-en-Y gastric bypass improves weight loss in the first years after surgery: results of a randomized controlled trial. Obes Surg. 2018;28(12):3744–55.
Holst JJ, Madsbad S, Bojsen-Møller KN, et al. Mechanisms in bariatric surgery: gut hormones, diabetes resolution, and weight loss. Surg Obes Relat Dis. 2018;14(5):708–14.
Mulla CM, Middelbeek RJ, Patti M-E. Mechanisms of weight loss and improved metabolism following bariatric surgery. Ann N Y Acad Sci. 2018;1411(1):53–64.
Heinberg LJ, Bond DS, Carroll I, et al. Identifying mechanisms that predict weight trajectory after bariatric surgery: rationale and design of the biobehavioral trial. Surg Obes Relat Dis. 2020;16(11):1816–26.
Elaine WY, Lee MP, Landon JE, et al. Fracture risk after bariatric surgery: Roux-en-Y gastric bypass versus adjustable gastric banding. J Bone Miner Res. 2017;32(6):1229–36.
Elnahas AI, Jackson TD, Hong D. Management of failed laparoscopic Roux-en-Y gastric bypass. Bariatr Surg Pract Patient Care. 2014;9(1):36–40.
Nora M, Morais T, Almeida R, et al. Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes? Medicine. 2017;96(48)
Koliaki C, Liatis S, le Roux CW, et al. The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr Disord. 2017;17(1):50.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.
Moon RC, Bornstein A, Teixeira AF, et al. Short-term results of long biliopancreatic limb Roux-en-Y gastric bypass—is it superior? Surg Obes Relat Dis. 2020;16(4):492–6.
Mahdy T, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: a retrospective cohort study. Int J Surg. 2016;34:28–34.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. Jama. 2004;292(14):1724–37.
Carr WRJ, Mahawar KK. LRYGB: Outcomes. In: Agrawal S, editor. Obesity, bariatric and metabolic surgery: a practical guide. Cham: Springer International Publishing; 2016. p. 231–8.
Salama TM, Sabry K, Ghamrini YE. Single anastomosis sleeve ileal bypass: new step in the evolution of bariatric surgeries. J Investig Surg. 2017;30(5):291–6.
Bal B, Shah H, Finelli F, et al. Hypoalbuminemia after Roux-en-Y gastric bypass surgery is not related to small intestinal bacterial overgrowth: 267. Off J Ame Coll Gastroenterol| ACG. 2008;103:S103.
Bordalo LA, Teixeira TFS, Bressan J, et al. Bariatric surgery: how and why to supplement. Rev Assoc Méd Bras (Engl Ed). 2011;57(1):111–8.
Brolin R, Gorman J, Gorman R, et al. Are vitamin B 12 and folate deficiency clinically important after Roux-en-Y gastric bypass? J Gastrointest Surg. 1998;2(5):436–42.
Madyan A, Emile SH, Abdel-Razik MA, et al. Laparoscopic single anastomosis sleeve ileal (SASI) bypass for patients with morbid obesity: technical description and short-term outcomes. Surg Laparosc Endosc Percutaneous Tech. 2020;30(2):e13–e7.
Author information
Authors and Affiliations
Contributions
Tarek Mahdy and Sameh Emile designed the study, participated in data collection and analysis, writing and revision of the manuscript. Abdulwahid Alwahedi, Waleed Gado and Carl Schou contributed to data interpretation, drafting, and critical revision of the final manuscript. Amr Madyan shared in data analysis and writing of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics approval for the study was obtained from the Research Ethics Committee.
Informed consent
Informed consent does not apply as for this type of study formal consent is not required.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• RYGB and SASI bypass were followed by a significant decrease in BMI and were comparable in terms of excess and total weight loss and improvement in comorbidities.
• The serum albumin levels showed a significant decline after RYGB, but not after SASI bypass.
• The postoperative serum iron levels were higher after SASI bypass than after RYGB.
• There was no significant difference in regards to complication rates.
Rights and permissions
About this article
Cite this article
Mahdy, T., Emile, S.H., Alwahedi, A. et al. Roux-en-Y Gastric Bypass with Long Biliopancreatic Limb Compared to Single Anastomosis Sleeve Ileal (SASI) Bypass in Treatment of Morbid Obesity. OBES SURG 31, 3615–3622 (2021). https://doi.org/10.1007/s11695-021-05457-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-021-05457-z